Scaffold Biotech
PrivateLast Round
Seed
Feb 1, 2024
Total Funding Raised
$750,000
Company Overview
Scaffold Biotech is a biotechnology company that develops next-generation subunit vaccines for animal health using protein engineering and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scaffold Biotech Comparables
Compare Scaffold Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genvax Technologies | 79% | |
| ArkVax | 74% | |
| Merck & Co., Inc. | 63% | |
Scaffold Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2024 |
Scaffold Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LAB+ Company Builder | Seed |
| Agencia Nacional de Investigación e Innovación | Seed |
Scaffold Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scaffold Biotech's valuation, stock price, and market status.